Researchers develop quinoline-based drug with inhibitory activity against the SARS-CoV-2 papain-like protease (PLpro).

Australian scientists developed a novel antiviral that targets the SARS-CoV-2 PLpro enzyme, showing strong preclinical ...

We ended up getting lucky with SARS. The coronavirus that caused it turned out to be far less infectious than it first ...

Coronaviruses include some variations of the common cold, the virus that causes MERS, severe acute respiratory syndrome (SARS ...

The newest one to make people sick causes COVID-19, also known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first record of illness linked to SARS-CoV-2 was in China in ...

Key findings • Sarcoidosis patients are prone to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, increased severity, morbidity and greater mortality of coronavirus disease 2019 ...

Otto and co-author Sean Edgerton, a PhD student focused on genomics and infectious diseases at the University of British ...

The first mention of Covid-19 in the Queens Chronicle came on Jan. 30, 2020, in a story headlined “Coronavirus fears seep ...

No increased risk for new-onset T2D was found after mild SARS-CoV-2 infection in a multiethnic Asian cohort during the ...

The risk for long COVID among pregnant individuals is lower than among matched nonpregnant women, according to study findings.

Severe Acute Respiratory Syndrome (SARS) is a disease that first appeared in humans in November 2002. Infection initially brings flu-like symptoms including fever and fatigue, but it then attacks ...

Five years after SARS-CoV-2 triggered a worldwide pandemic, leading to widespread devastation, another bat-borne coronavirus ...